Detalhe da pesquisa
1.
Noncancerous disease-targeting AIEgens.
Chem Soc Rev
; 52(3): 1024-1067, 2023 Feb 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-36602333
2.
A carrier-free supramolecular nano-twin-drug for overcoming irinotecan-resistance and enhancing efficacy against colorectal cancer.
J Nanobiotechnology
; 21(1): 393, 2023 Oct 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-37898773
3.
Visualization of human T lymphocyte-mediated eradication of cancer cells in vivo.
Proc Natl Acad Sci U S A
; 117(37): 22910-22919, 2020 09 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-32859758
4.
Photothermal and Enhanced Photocatalytic Therapies Conduce to Synergistic Anticancer Phototherapy with Biodegradable Titanium Diselenide Nanosheets.
Small
; 17(40): e2103239, 2021 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-34486220
5.
Emerging combination strategies with phototherapy in cancer nanomedicine.
Chem Soc Rev
; 49(22): 8065-8087, 2020 Nov 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-32567633
6.
Tumor-Exocytosed Exosome/Aggregation-Induced Emission Luminogen Hybrid Nanovesicles Facilitate Efficient Tumor Penetration and Photodynamic Therapy.
Angew Chem Int Ed Engl
; 59(33): 13836-13843, 2020 08 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-32367646
7.
Novel Carrier-Free Nanodrug Enhances Photodynamic Effects by Blocking the Autophagy Pathway and Synergistically Triggers Immunogenic Cell Death for the Efficient Treatment of Breast Cancer.
ACS Appl Mater Interfaces
; 16(5): 5683-5695, 2024 Feb 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-38261396
8.
Bacteria-targeted delivery of black phosphorus quantum dots facilitates photothermal therapy against hypoxic tumors and complementary low-dose radiotherapy.
Biomater Sci
; 11(13): 4727-4740, 2023 Jun 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-37249003
9.
A simple strategy for the efficient design of mitochondria-targeting NIR-II phototheranostics.
J Mater Chem B
; 11(12): 2700-2705, 2023 03 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-36857751
10.
Combination of bacterial-targeted delivery of gold-based AIEgen radiosensitizer for fluorescence-image-guided enhanced radio-immunotherapy against advanced cancer.
Bioact Mater
; 30: 200-213, 2023 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-37663305
11.
Multifunctional Calcium-Manganese Nanomodulator Provides Antitumor Treatment and Improved Immunotherapy via Reprogramming of the Tumor Microenvironment.
ACS Nano
; 17(16): 15449-15465, 2023 08 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-37530575
12.
Macrophages in immunoregulation and therapeutics.
Signal Transduct Target Ther
; 8(1): 207, 2023 05 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-37211559
13.
Aggregation-Induced Emission (AIE), Life and Health.
ACS Nano
; 17(15): 14347-14405, 2023 08 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-37486125
14.
AIEgen-Based Bionic Nanozymes for the Interventional Photodynamic Therapy-Based Treatment of Orthotopic Colon Cancer.
ACS Appl Mater Interfaces
; 2022 May 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-35543331
15.
Dcf1 induces glioblastoma cells apoptosis by blocking autophagy.
Cancer Med
; 11(1): 207-223, 2022 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34799992
16.
Light-induced tumor theranostics based on chemical-exfoliated borophene.
Light Sci Appl
; 11(1): 324, 2022 Nov 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-36369148
17.
Bright Bacterium for Hypoxia-Tolerant Photodynamic Therapy Against Orthotopic Colon Tumors by an Interventional Method.
Adv Sci (Weinh)
; 8(15): e2004769, 2021 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-34145986
18.
Patient-derived microvesicles/AIE luminogen hybrid system for personalized sonodynamic cancer therapy in patient-derived xenograft models.
Biomaterials
; 272: 120755, 2021 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-33819814
19.
Development of MOF "Armor-Plated" Phycocyanin and Synergistic Inhibition of Cellular Respiration for Hypoxic Photodynamic Therapy in Patient-Derived Xenograft Models.
Adv Healthc Mater
; 10(3): e2001577, 2021 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-33274821
20.
Off-tumor IDO1 target engagements determine the cancer-immune set point and predict the immunotherapeutic efficacy.
J Immunother Cancer
; 9(6)2021 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-34148865